| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | EVP, Head Of Development &CMO | Chief Medical Officer
3 companies
Agarwal Sunil is an EVP, Head Of Development &CMO at SANA with holdings across 3 companies. Recent SEC Form 4 filings include 0 buys and 9 sells.
Estimated insider holdings value: $5.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 20, 2015 | RARE Ultragenyx Pharmaceutical Inc. | Chief Medical Officer | Sell | 649 | $85.51 | $55,495.99 | -4.2% | |
| Sep 22, 2015 | RARE Ultragenyx Pharmaceutical Inc. | Chief Medical Officer | Sell | 498 | $109.51 | $54,535.98 | -3.0% | |
| Aug 20, 2015 | RARE Ultragenyx Pharmaceutical Inc. | Chief Medical Officer | Sale+OE | 17,020 | $111.18 | $1,892,211.88 | -10.6% |